Lasa Supergenerics adds oxyclozanide to its product portfolio
Setting up new capacity as a brownfield expansion, production to commence from August 2021
Lasa Supergenerics, a producer of veterinary and human APIs in India has added another product – Oxyclozanide to its portfolio of products.
Oxyclozanide is an anthelmintic used in the treatment and control of fascioliasis a topical worm infection in ruminants mainly domestic animals such as cattle (especially buffalos on farm), sheep, and goats. For this, the company is setting up capacity in a brownfield expansion at its Chiplun unit. The total capacity would be 250 MT and The Company is committed to funding the required Capex through internal accruals. The production would start from August 2021.
A company statement informed, “The product is in huge demand and the management is confident of having a strong order book from the time production commences. The company already has export approvals for several regions. Oxyclozanide would also be exported to these regions.”
- Advertisement -